BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 30646278)

  • 1. Incidence of Placebo Adverse Events in Randomized Clinical Trials of Targeted and Immunotherapy Cancer Drugs in the Adjuvant Setting: A Systematic Review and Meta-analysis.
    Chacón MR; Enrico DH; Burton J; Waisberg FD; Videla VM
    JAMA Netw Open; 2018 Dec; 1(8):e185617. PubMed ID: 30646278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of Adverse Events in the Placebo Arms of COVID-19 Vaccine Trials: A Systematic Review and Meta-analysis.
    Haas JW; Bender FL; Ballou S; Kelley JM; Wilhelm M; Miller FG; Rief W; Kaptchuk TJ
    JAMA Netw Open; 2022 Jan; 5(1):e2143955. PubMed ID: 35040967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerability of selective cyclooxygenase 2 inhibitors used for the treatment of rheumatological manifestations of inflammatory bowel disease.
    Miao XP; Li JS; Ouyang Q; Hu RW; Zhang Y; Li HY
    Cochrane Database Syst Rev; 2014 Oct; (10):CD007744. PubMed ID: 25340915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse event profiles of epidermal growth factor receptor-tyrosine kinase inhibitors in cancer patients: A systematic review and meta-analysis.
    Yin X; Zhao Z; Yin Y; Shen C; Chen X; Cai Z; Wang J; Chen Z; Yin Y; Zhang B
    Clin Transl Sci; 2021 May; 14(3):919-933. PubMed ID: 33382906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Types, frequencies, and burden of nonspecific adverse events of drugs: analysis of randomized placebo-controlled clinical trials.
    Mahr A; Golmard C; Pham E; Iordache L; Deville L; Faure P
    Pharmacoepidemiol Drug Saf; 2017 Jul; 26(7):731-741. PubMed ID: 28176407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of adverse events attribution and reporting in cancer clinical trials: A systematic review.
    Enrico D; Waisberg F; Burton J; Mandó P; Chacón M
    Crit Rev Oncol Hematol; 2021 Apr; 160():103296. PubMed ID: 33675904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with disease-modifying drugs for people with a first clinical attack suggestive of multiple sclerosis.
    Filippini G; Del Giovane C; Clerico M; Beiki O; Mattoscio M; Piazza F; Fredrikson S; Tramacere I; Scalfari A; Salanti G
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD012200. PubMed ID: 28440858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placebo Responses Among Men With Erectile Dysfunction Enrolled in Phosphodiesterase 5 Inhibitor Trials: A Systematic Review and Meta-analysis.
    Stridh A; Pontén M; Arver S; Kirsch I; Abé C; Jensen KB
    JAMA Netw Open; 2020 Mar; 3(3):e201423. PubMed ID: 32196105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular Adverse Events Associated With BRAF and MEK Inhibitors: A Systematic Review and Meta-analysis.
    Mincu RI; Mahabadi AA; Michel L; Mrotzek SM; Schadendorf D; Rassaf T; Totzeck M
    JAMA Netw Open; 2019 Aug; 2(8):e198890. PubMed ID: 31397860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of Symptomatic Slow-Acting Drugs for Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis.
    Honvo G; Reginster JY; Rabenda V; Geerinck A; Mkinsi O; Charles A; Rizzoli R; Cooper C; Avouac B; Bruyère O
    Drugs Aging; 2019 Apr; 36(Suppl 1):65-99. PubMed ID: 31073924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse event profile for immunotherapy agents compared with chemotherapy in solid organ tumors: a systematic review and meta-analysis of randomized clinical trials.
    Magee DE; Hird AE; Klaassen Z; Sridhar SS; Nam RK; Wallis CJD; Kulkarni GS
    Ann Oncol; 2020 Jan; 31(1):50-60. PubMed ID: 31912796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and Tolerability of PD-1/PD-L1 Inhibitors Compared with Chemotherapy in Patients with Advanced Cancer: A Meta-Analysis.
    Nishijima TF; Shachar SS; Nyrop KA; Muss HB
    Oncologist; 2017 Apr; 22(4):470-479. PubMed ID: 28275115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of Intra-articular Hyaluronic Acid Injections in Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis.
    Honvo G; Reginster JY; Rannou F; Rygaert X; Geerinck A; Rabenda V; McAlindon T; Charles A; Fuggle N; Cooper C; Curtis E; Arden N; Avouac B; Bruyère O
    Drugs Aging; 2019 Apr; 36(Suppl 1):101-127. PubMed ID: 31073925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of addition of VEGFR and EGFR-family oral small-molecule tyrosine kinase inhibitors to cytotoxic chemotherapy in solid cancers: a systematic review and meta-analysis of randomized controlled trials.
    Funakoshi T; Latif A; Galsky MD
    Cancer Treat Rev; 2014 Jun; 40(5):636-47. PubMed ID: 24629273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of Endocrine Dysfunction Following the Use of Different Immune Checkpoint Inhibitor Regimens: A Systematic Review and Meta-analysis.
    Barroso-Sousa R; Barry WT; Garrido-Castro AC; Hodi FS; Min L; Krop IE; Tolaney SM
    JAMA Oncol; 2018 Feb; 4(2):173-182. PubMed ID: 28973656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of Cyclooxygenase-2 Inhibitors in Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis.
    Curtis E; Fuggle N; Shaw S; Spooner L; Ntani G; Parsons C; Corp N; Honvo G; Baird J; Maggi S; Dennison E; Bruyère O; Reginster JY; Cooper C
    Drugs Aging; 2019 Apr; 36(Suppl 1):25-44. PubMed ID: 31073922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotics for induction and maintenance of remission in Crohn's disease.
    Townsend CM; Parker CE; MacDonald JK; Nguyen TM; Jairath V; Feagan BG; Khanna R
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD012730. PubMed ID: 30731030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probiotics for the prevention of pediatric antibiotic-associated diarrhea.
    Goldenberg JZ; Lytvyn L; Steurich J; Parkin P; Mahant S; Johnston BC
    Cochrane Database Syst Rev; 2015 Dec; (12):CD004827. PubMed ID: 26695080
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.